Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Leonard Pogach, MD, MBA

Articles by Leonard Pogach, MD, MBA

Facility Variation in Utilization of Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes Mellitus and Chronic Kidney Disease

ByAnjali Tiwari, MBBS, MS,Chin-Lin Tseng, DrPH,Elizabeth F. O. Kern, MD,Miriam Maney, MA, CHPQ,Donald R. Miller, ScD,Leonard Pogach, MD, MBA

February 1st 2007

Diabetes Healthcare Quality Report Cards: How Accurate Are the Grades?

ByLeonard Pogach, MD, MBA,Minge Xie, PhD,Yue Shentue, BA,Chin-Lin Tseng, DrPH,Miriam Maney, MA,Mangala Rajan, MBA,Anjali Tiwari, MD,John Kolassa, PhD,Drew Helmer, MD,Stephen Crystal, PhD,Monika Safford, MD

December 1st 2005

Impact of Policies and Performance Measurement on Development of Organizational Coordinating Strategies for Chronic Care Delivery

ByLeonard Pogach, MD, MBA,Martin P. Charns, MBA, DBA,James S. Wrobel, DPM, MS,Jeffrey M. Robbins, DPM,Kristin M. Bonacker, BA,Linda Haas, PhC, RN, CDE,Gayle E. Reiber, MPH, PhD

February 1st 2004

Latest Updated Articles

Facility Variation in Utilization of Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes Mellitus and Chronic Kidney Disease
Published: February 1st 2007 | Updated:
Impact of Policies and Performance Measurement on Development of Organizational Coordinating Strategies for Chronic Care Delivery
Published: February 1st 2004 | Updated:
Diabetes Healthcare Quality Report Cards: How Accurate Are the Grades?
Published: December 1st 2005 | Updated:

Trending on AJMC

Trump Administration Flags Potential Link Between Prenatal Acetaminophen Use, Autism

Patient Cost, Convenience Important Considerations When Reviewing Formulary Approvals in Oncology: Q&A With Andrea Iannucci, PharmD, BCOP

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.